NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/11/2024
Back to search
Official data from USPTO
ALCRESTA THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ALCRESTA THERAPEUTICS
ST13
US500000087066536Class
5, 10
Filing
87066536
Registration
5387508
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
06/11/2024
Trademark type
Word
Nice classes
5, 10
Filing date
06/09/2016
Registration date
01/23/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/11/2024
Last transaction
06/11/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/16/2016
First use in commerce
06/16/2016
Drawing code
4
Owner type
03
Owner location
Waltham, MA
Examiner
FRIEDMAN, LESLEE ANN
Current location
Historical data usage
Holders and representatives
Holders
ALCRESTA THERAPEUTICS, INC.
ALCRESTA THERAPEUTICS, INC.
Alcresta, Inc.
Representatives
Perry J. Viscounty, Esq. Latham & Watkins LLP
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medical nutritional formulaformula for use as a nutritional supplement; infant formula; dietetic foods adapted for medical use; enzyme food supplements and enzymes for medical purposes; dietary and nutritional supplements; pharmaceutical preparations for the treatment of nutritionalgastrointestinaldigestivemetabolicurologicalnephrologyendocrineoncologicrheumatologicinflammatorypediatricelderlyimmunologiccardiovasculardermatologichematologicinfectiouscirculatorysurgery and would healingmental illnesspulmonarymuscular and respiratory diseases and disorders
Class 10
Medical devicea single use point-of-care enteral feeding cartridge that is designed to fit in-line with enteral feed circuits to optimize fluid dynamics and hydrolytic absorption of certain enzymes and fats
Publications
History of USPTO decisions and trademark events.
37 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/11/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/11/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
03/20/2024
E815
TEAS SECTION 8 & 15 RECEIVED
12/06/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/17/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/17/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/17/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/17/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/17/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/23/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
01/23/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/22/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/21/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/20/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/19/2017
EX1G
SOU EXTENSION 1 GRANTED
12/19/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/19/2017
EXT1
SOU EXTENSION 1 FILED
12/14/2017
EEXT
SOU TEAS EXTENSION RECEIVED
12/14/2017
IUAF
USE AMENDMENT FILED
12/13/2017
EISU
TEAS STATEMENT OF USE RECEIVED
12/13/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/20/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/25/2017
PUBO
PUBLISHED FOR OPPOSITION
04/25/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/05/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/10/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/07/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/06/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/06/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/21/2016
GNRT
NON-FINAL ACTION E-MAILED
09/21/2016
CNRT
NON-FINAL ACTION WRITTEN
09/21/2016
DOCK
ASSIGNED TO EXAMINER
09/20/2016
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/06/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/16/2016
NWAP
NEW APPLICATION ENTERED
06/13/2016
Continuous trademark protection
Get notified about every new filing that threatens ALCRESTA THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.